Non-alcoholic fatty liver disease and non-alcoholic steato-hepatitis are common in patients undergoing bariatric surgery. Non-alcoholic steato-hepatitis can progress to cirrhosis of the liver and hepatocellular carcinoma. Non-invasive methods of diagnosing non-alcoholic steato-hepatitis are not as accurate as liver biopsy, and bariatric surgery presents a unique opportunity to carry out a simultaneous liver biopsy. Routine liver biopsy can help early and accurate diagnosis of obesity-associated liver conditions. This has led some surgeons to argue for routine liver biopsy at the time of bariatric surgery. However, most bariatric surgeons remain unconvinced and liver biopsy is currently not routine practice with bariatric surgery. This revie...
Background: Nonalcoholic fatty liver disease (NAFLD) increases the risk of liver cirrhosis and hepat...
The prevalence of obesity and metabolic diseases such as type 2 diabetes and nonalcoholic fatty live...
Weight loss is a therapeutic solution for many metabolic disorders, such as obesity and its complica...
Nonalcoholic steatohepatitis (NASH) is a morbid condition highly related to obesity. It is unclear i...
Background: Liver biopsy remains the gold standard for characterizing and evaluating treatment respo...
ABSTRACT- Background: Metabolic disorders have high correlation with severe forms of nonalcoholic fa...
© 2006 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserv...
ABSTRACT CONTEXT AND OBJECTIVE: Nonalcoholic fatty liver disease (NAFLD) has been increasingly diag...
Purpose: Metabolic dysfunction-associated fatty liver disease-related cirrhosis is possible at the t...
Obesity is a risk factor for nonalcoholic fatty liver disease (NAFLD), which appears to improve afte...
Background. Bariatric surgery patients have a higher prevalence of nonalcoholic fatty liver (NAFL) t...
Introduction; p to 300 million people have the body mass index (BMI) greater than 30 kg/m2. Obesity ...
Background: Obesity is the most frequent risk factor associated with NAFLD, and bariatric surgery (B...
PURPOSE: To determine the prevalence of non alcoholic fatty liver disease (NAFLD) and non alcoholic ...
Background/Aim: Morbidly obese patients have a high prevalence of fatty liver disease and its seriou...
Background: Nonalcoholic fatty liver disease (NAFLD) increases the risk of liver cirrhosis and hepat...
The prevalence of obesity and metabolic diseases such as type 2 diabetes and nonalcoholic fatty live...
Weight loss is a therapeutic solution for many metabolic disorders, such as obesity and its complica...
Nonalcoholic steatohepatitis (NASH) is a morbid condition highly related to obesity. It is unclear i...
Background: Liver biopsy remains the gold standard for characterizing and evaluating treatment respo...
ABSTRACT- Background: Metabolic disorders have high correlation with severe forms of nonalcoholic fa...
© 2006 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserv...
ABSTRACT CONTEXT AND OBJECTIVE: Nonalcoholic fatty liver disease (NAFLD) has been increasingly diag...
Purpose: Metabolic dysfunction-associated fatty liver disease-related cirrhosis is possible at the t...
Obesity is a risk factor for nonalcoholic fatty liver disease (NAFLD), which appears to improve afte...
Background. Bariatric surgery patients have a higher prevalence of nonalcoholic fatty liver (NAFL) t...
Introduction; p to 300 million people have the body mass index (BMI) greater than 30 kg/m2. Obesity ...
Background: Obesity is the most frequent risk factor associated with NAFLD, and bariatric surgery (B...
PURPOSE: To determine the prevalence of non alcoholic fatty liver disease (NAFLD) and non alcoholic ...
Background/Aim: Morbidly obese patients have a high prevalence of fatty liver disease and its seriou...
Background: Nonalcoholic fatty liver disease (NAFLD) increases the risk of liver cirrhosis and hepat...
The prevalence of obesity and metabolic diseases such as type 2 diabetes and nonalcoholic fatty live...
Weight loss is a therapeutic solution for many metabolic disorders, such as obesity and its complica...